Prognostic value of the CALLY and triglyceride-glucose indices in non-diabetic NSTEMI with multivessel disease: the role of revascularization completeness

Background The triglyceride-glucose (TyG) and C-reactive protein-albumin-lymphocyte (CALLY) indices reflect metabolic and inflammatory-nutritional risk, but their prognostic value in non-diabetic patients with non-ST-elevation myocardial infarction (NSTEMI) and multivessel disease, and whether this value depends on revascularization status, is unknown. We examined the association of both indices with one-year major adverse cardiovascular events (MACE) and their incremental value over the GRACE score. Methods We retrospectively studied 1,424 non-diabetic NSTEMI patients with multivessel disease, of whom 738 (51.8%) underwent complete revascularization (CR) and 686 (48.2%) incomplete revascularization (ICR). The prognostic value of each index was assessed by ROC analysis, Kaplan–Meier survival, and Cox regression, and their incremental value over GRACE by reclassification metrics. Results MACE occurred in 174 patients (12.2%) over one year. The CALLY index predicted risk in both groups, with an approximately fourfold risk in the lowest versus the highest tertile (adjusted HR 4.23), and its effect did not vary with revascularization status (interaction p = 0.40). The prognostic association of TyG appeared to differ by revascularization status: it was significant after CR (HR 2.66) but not after ICR (HR 1.42), although the interaction did not reach significance ( p = 0.070). Adding both indices improved discrimination beyond GRACE (C-index 0.694 to 0.743; continuous net reclassification improvement 0.259 for CALLY). Conclusion In non-diabetic NSTEMI with multivessel disease, the CALLY index is a revascularization-independent prognostic marker, whereas the prognostic value of the TyG index appeared mainly in patients with complete revascularization, suggesting a possible trend toward effect modification that requires confirmation. Interpreted in the context of revascularization, these two readily available indices may refine risk stratification beyond the GRACE score.

Authors

Institutions

Publication Details

Journal
Frontiers in Cardiovascular Medicine
Published
2026-11-18
DOI
https://doi.org/10.3389/fcvm.2026.1949301
Primary Topic
Inflammatory Biomarkers in Disease Prognosis
Type
article
Field-Weighted Citation Impact
0.00
Controls
|||
ALL TIME
JAN
FEB
MAR
APR
MAY
JUN
JUL
AUG
SEP
OCT
NOV
article

Prognostic value of the CALLY and triglyceride-glucose indices in non-diabetic NSTEMI with multivessel disease: the role of revascularization completeness

Gökhan Cabri, Gülşen Genç Tapar, Metin Karayakalı, Samet Yılmaz et al.
3 links
Frontiers in Cardiovascular Medicine
Inflammatory Biomarkers in Disease Prognosis
article

Prognostic value of the CALLY and triglyceride-glucose indices in non-diabetic NSTEMI with multivessel disease: the role of revascularization completeness

Gökhan Cabri, Gülşen Genç Tapar, Metin Karayakalı, Samet Yılmaz, Arif Arısoy, Volkan Yılmaz, VELİ AKIN
article en

Abstract

Background The triglyceride-glucose (TyG) and C-reactive protein-albumin-lymphocyte (CALLY) indices reflect metabolic and inflammatory-nutritional risk, but their prognostic value in non-diabetic patients with non-ST-elevation myocardial infarction (NSTEMI) and multivessel disease, and whether this value depends on revascularization status, is unknown. We examined the association of both indices with one-year major adverse cardiovascular events (MACE) and their incremental value over the GRACE score. Methods We retrospectively studied 1,424 non-diabetic NSTEMI patients with multivessel disease, of whom 738 (51.8%) underwent complete revascularization (CR) and 686 (48.2%) incomplete revascularization (ICR). The prognostic value of each index was assessed by ROC analysis, Kaplan–Meier survival, and Cox regression, and their incremental value over GRACE by reclassification metrics. Results MACE occurred in 174 patients (12.2%) over one year. The CALLY index predicted risk in both groups, with an approximately fourfold risk in the lowest versus the highest tertile (adjusted HR 4.23), and its effect did not vary with revascularization status (interaction p = 0.40). The prognostic association of TyG appeared to differ by revascularization status: it was significant after CR (HR 2.66) but not after ICR (HR 1.42), although the interaction did not reach significance ( p = 0.070). Adding both indices improved discrimination beyond GRACE (C-index 0.694 to 0.743; continuous net reclassification improvement 0.259 for CALLY). Conclusion In non-diabetic NSTEMI with multivessel disease, the CALLY index is a revascularization-independent prognostic marker, whereas the prognostic value of the TyG index appeared mainly in patients with complete revascularization, suggesting a possible trend toward effect modification that requires confirmation. Interpreted in the context of revascularization, these two readily available indices may refine risk stratification beyond the GRACE score.

Frontiers in Cardiovascular MedicineVol. 13
Başkent University (TR), Tokat Gaziosmanpaşa Üniversitesi (TR)
Good health and well-being
Inflammatory Biomarkers in Disease Prognosis
AI Navigator

Ask Laika to Summarize, Analyze, and Connect papers live on the map.

Summarize Papers & Methodologies

Extract key findings, datasets, and comparative methods across publications.

Benchmark Rankings & Visual Analytics

Rank top research institutions, authors, funders, topics, and journals by Field-Weighted Citation Impact (FWCI) and paper volume with instant charts.

Connect Distant Disciplines

Bridge topological clusters on the map to find hidden collaborative intersections.

Laika access coming soon